ACTIVE_NOT_RECRUITING

Improving Hypertension Medication Adherence for Older Adults

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized controlled trial will assess the efficacy and scalability of a blood pressure technology system intervention. The investigators will enroll 224 older adults with hypertension to identify those who are nonadherent for one hypertension medication. The participants will be randomized to one of two groups (112 per group) to use the blood pressure system for 6-months. Both groups receive information about high blood pressure and medications. One group will also receive strategies that can be used to take medications and manage blood pressure. Both groups will complete a mid-assessment at 3-months and a post-assessment at 6-months.

Official Title

Improving Hypertension Medication Adherence for Older Adults

Quick Facts

Study Start:2022-11-02
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05610059

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age 65 years or older
  2. * self-manage at least one hypertension medication
  3. * able to read and speak English
  4. * willing to participate in the study for six months
  5. * currently have and use an Apple iPhone
  6. * have hypertension medication adherence ≤ 90% in the last 2 weeks of the 4-week baseline monitoring period using an AARDEX MEMS® cap
  1. * have inadequate visual acuity (worse than 20/50 corrected near vision on Snellen test)
  2. * experience severe depression (\> 11 on Geriatric Depression Scale Short Form, GDS-15)
  3. * are at risk for cognitive impairment (\< 23 on Montreal Cognitive Assessment, MoCA)
  4. * been instructed by their healthcare provider to withhold their blood pressure medication

Contacts and Locations

Study Locations (Sites)

University of Arizona
Tucson, Arizona, 85721
United States
University of Illinois Urbana-Champaign
Champaign, Illinois, 61820
United States

Collaborators and Investigators

Sponsor: University of Arizona

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-02
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2022-11-02
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Aging
  • Medication Adherence
  • Hypertension